| Dr Elizabeth Cate Roede Barbee, MD | |
|
10941 Raven Ridge Rd, Suite 109, Raleigh, NC 27614-6487 | |
| (919) 847-7420 | |
| (919) 847-7471 |
| Full Name | Dr Elizabeth Cate Roede Barbee |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 25 Years |
| Location | 10941 Raven Ridge Rd, Raleigh, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548273899 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VG0400X | Obstetrics & Gynecology - Gynecology | (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wakemed, Raleigh Campus | Raleigh, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Uwh Of The Carolinas Pllc | 0042448169 | 290 |
News Archive
Hyperion Therapeutics today announced that the first patient has been enrolled in a clinical trial of investigational compound HPN-100 (glycerol phenylbutyrate) in children ages 6-17 with urea cycle disorders (UCD). The study will evaluate the safety, tolerability, and ammonia control of glycerol phenylbutyrate compared to BUPHENYL® (sodium phenylbutyrate).
UT Southwestern Medical Center cell biologists have identified a new method for determining the length of telomeres, the endcaps of chromosomes, which can influence cancer progression and aging.
Scientists at Dana-Farber Cancer Institute and the Broad Institute have found strikingly high levels of a bacterium in colorectal cancers, a sign that it might contribute to the disease and potentially be a key to diagnosing, preventing, and treating it.
Patients with a disease that is a leading cause of kidney failure tend to have high levels of a particular factor circulating in their blood, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
AMDL, Inc. has announced that it has received an important Israeli patent for an animal model for the evaluation of vaccines, which is a part of its unique Combination Immune Therapy (CIT) technology.
› Verified 9 days ago
| Entity Name | Gynecology & Laparoscopic Surgeons, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578527446 PECOS PAC ID: 0941285977 Enrollment ID: O20040623000103 |
News Archive
Hyperion Therapeutics today announced that the first patient has been enrolled in a clinical trial of investigational compound HPN-100 (glycerol phenylbutyrate) in children ages 6-17 with urea cycle disorders (UCD). The study will evaluate the safety, tolerability, and ammonia control of glycerol phenylbutyrate compared to BUPHENYL® (sodium phenylbutyrate).
UT Southwestern Medical Center cell biologists have identified a new method for determining the length of telomeres, the endcaps of chromosomes, which can influence cancer progression and aging.
Scientists at Dana-Farber Cancer Institute and the Broad Institute have found strikingly high levels of a bacterium in colorectal cancers, a sign that it might contribute to the disease and potentially be a key to diagnosing, preventing, and treating it.
Patients with a disease that is a leading cause of kidney failure tend to have high levels of a particular factor circulating in their blood, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
AMDL, Inc. has announced that it has received an important Israeli patent for an animal model for the evaluation of vaccines, which is a part of its unique Combination Immune Therapy (CIT) technology.
› Verified 9 days ago
| Entity Name | Uwh Of The Carolinas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639506470 PECOS PAC ID: 0042448169 Enrollment ID: O20140118000107 |
News Archive
Hyperion Therapeutics today announced that the first patient has been enrolled in a clinical trial of investigational compound HPN-100 (glycerol phenylbutyrate) in children ages 6-17 with urea cycle disorders (UCD). The study will evaluate the safety, tolerability, and ammonia control of glycerol phenylbutyrate compared to BUPHENYL® (sodium phenylbutyrate).
UT Southwestern Medical Center cell biologists have identified a new method for determining the length of telomeres, the endcaps of chromosomes, which can influence cancer progression and aging.
Scientists at Dana-Farber Cancer Institute and the Broad Institute have found strikingly high levels of a bacterium in colorectal cancers, a sign that it might contribute to the disease and potentially be a key to diagnosing, preventing, and treating it.
Patients with a disease that is a leading cause of kidney failure tend to have high levels of a particular factor circulating in their blood, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
AMDL, Inc. has announced that it has received an important Israeli patent for an animal model for the evaluation of vaccines, which is a part of its unique Combination Immune Therapy (CIT) technology.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth Cate Roede Barbee, MD 102 Sequoia Ct, Cary, NC 27513-4754 Ph: (919) 468-8122 | Dr Elizabeth Cate Roede Barbee, MD 10941 Raven Ridge Rd, Suite 109, Raleigh, NC 27614-6487 Ph: (919) 847-7420 |
News Archive
Hyperion Therapeutics today announced that the first patient has been enrolled in a clinical trial of investigational compound HPN-100 (glycerol phenylbutyrate) in children ages 6-17 with urea cycle disorders (UCD). The study will evaluate the safety, tolerability, and ammonia control of glycerol phenylbutyrate compared to BUPHENYL® (sodium phenylbutyrate).
UT Southwestern Medical Center cell biologists have identified a new method for determining the length of telomeres, the endcaps of chromosomes, which can influence cancer progression and aging.
Scientists at Dana-Farber Cancer Institute and the Broad Institute have found strikingly high levels of a bacterium in colorectal cancers, a sign that it might contribute to the disease and potentially be a key to diagnosing, preventing, and treating it.
Patients with a disease that is a leading cause of kidney failure tend to have high levels of a particular factor circulating in their blood, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
AMDL, Inc. has announced that it has received an important Israeli patent for an animal model for the evaluation of vaccines, which is a part of its unique Combination Immune Therapy (CIT) technology.
› Verified 9 days ago
Dr. Matthew F Alvarez, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2417 Atrium Dr, Suite 200, Raleigh, NC 27607 Phone: 919-781-9555 Fax: 919-781-1070 | |
Mary Carolyn Peavey, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7920 Acc Blvd Ste 300, Raleigh, NC 27617 Phone: 214-868-0701 | |
Dr. Anna Fleischman, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 505 Oberlin Rd Ste 230, Raleigh, NC 27605 Phone: 919-235-6514 | |
James J Hardy, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4420 Lake Boone Trl, Raleigh, NC 27607 Phone: 919-784-3100 | |
Windsor Austin Holt, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3404 Wake Forest Rd, Suite 100, Raleigh, NC 27609 Phone: 919-876-8225 Fax: 919-876-3371 | |
Dr. Andrew John Cracker, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1604 Jones Franklin Road, Raleigh, NC 27606 Phone: 888-562-7415 | |
Mr. Paul Burt Harden Jr., MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3805 Computer Dr, Raleigh, NC 27609 Phone: 919-781-6200 Fax: 919-783-1819 |